SCHEMBL28657657

SCHEMBL28657657

NC(N)=NN=Cc1ccncc1Cl

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 11/20 0.60
GRIN3B O60391 11/20 0.60
GRIN1 Q05586 11/20 0.60
GRIN2A Q12879 11/20 0.60
GRIN2B Q13224 11/20 0.60
GRIN2C Q14957 11/20 0.60
GRIN3A Q8TCU5 11/20 0.60
NPSR1 Q6W5P4 4/20 0.57
MAPT P10636 1/20 0.57
PPP1R15A O75807 1/20 0.53
MELK Q14680 1/20 0.53
PPP1R15B Q5SWA1 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
SMN1; SMN2 Q16637 2/20 0.49
SLC22A1 O15245 1/20 0.49
HTR1A P08908 1/20 0.49
ADRA2A P08913 1/20 0.49
CHRM1 P11229 1/20 0.49
ADRA2B P18089 1/20 0.49
ADRA2C P18825 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28647145 0.77 GRIN2D (0.37) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL4637844 0.77 GAA (0.42) L3MBTL1KMT2ATSHR
SCHEMBL4637840 0.77 GAA (0.42) L3MBTL1KMT2ATSHR
SCHEMBL29445212 0.75 GRIN2D (1.00) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL15884162 0.75 GRIN2D (1.00) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL15875061 0.73 KMT2A (0.39) NPSR1MAPTL3MBTL1SMN1; SMN2KMT2A
SCHEMBL15875058 0.73 KMT2A (0.39) NPSR1MAPTL3MBTL1SMN1; SMN2KMT2A
Hydrochloric Acid SCHEMBL5703155 0.71 GRIN2D (1.00) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL22431375 0.71 HTT (0.36) NPSR1MAPTL3MBTL1KMT2ANPC1
SCHEMBL4637787 0.70 GAA (0.39) NPSR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107074752-B Therapeutic use of benzylidene guanidine derivatives for the treatment of protein conformation disorders 英费列特斯生命科学公司 2021-10-26 CN disclosed